Norry-Biotech
Latest round
- Series A
Last raised
- Feb 2026
Total raised
- Undisclosed
Investors
- 1
About Norry-Biotech
, Ltd, trading as Norry-Biotech, is a new drugs R&D company that focuses on the R&D of radiopharmaceuticals, with a research and development team consisting of more than 60 talents. The company and the affiliated Hospital of Jiangnan University have co-established an R&D platform. The firm has established partnerships with SIMN, Sumgen, Doer Biologics, etc. The company engages in the R&D of radiopharmaceuticals and has completed multiple target screening and development, including pancreatic, kidney, stomach, ovarian, and prostate cancer. It has developed the clinical translation platform, nuclear drug GMP production platform, fast screening ARC platform, and cloud-based imaging platform and provides automated solutions for the nuclear pharmaceutical industry, from nuclide purification, nuclear drug development/production, nuclear drug dispensing, injection, etc. The company's revenue is generated by providing radiopharmaceuticals.
Who invested in Norry-Biotech
1 investor across 1 round
See all investors in Norry-Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 28, 2026
Amount
Undisclosed
Investors
Questions about Norry-Biotech
Who invested in Norry-Biotech?
Norry-Biotech has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Norry-Biotech raised?
Norry-Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Norry-Biotech last raise money?
Norry-Biotech's most recent round on record is a Series A, in Feb 2026.
What does Norry-Biotech do?
, Ltd, trading as Norry-Biotech, is a new drugs R&D company that focuses on the R&D of radiopharmaceuticals, with a research and development team consisting of more than 60 talents.
Where is Norry-Biotech headquartered?
Norry-Biotech is headquartered in Wuxi, China.
Which VCs invest in companies like Norry-Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Norry-Biotech's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Norry-Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.